10Jun
02Jun
ZetrOZ Provides Veterans With Proven Non-Invasive, Non-Narcotic Pain Relief and Soft Tissue Healing
Dr. Ervin Rodriguez, a retired first sergeant and Army Ranger, suffered several soft tissue injuries during his military career. Now he relies on ZetrOZ Systems' sustained acoustic medicine (SAM) device for effective and non-narcotic pain relief. ZetrOZ Systems is the developer of the SAM 2.0 long-duration, wearable ultrasound treatment. Read more >>
26May
ZetrOZ Shares Lessons Learned in Medical Technology with Med Device Online
In the most current article of Medical Device Online, Dr. George Lewis, creator of the ZetrOZ sustained acoustic medicine (SAM) system, shared his experiences of the obstacles keeping innovative medical technology from widespread use and ways medical device developers can surmount those challenges. Read more >>
14Jan
ZetrOZ Systems Announces Expansion of Sustained Acoustic Medicine (SAM) Continuing Medical Education Courses
ZetrOZ Systems, developers of the Sustained Acoustic Medicine (SAM) wearable ultrasound, an FDA-cleared bio regenerative medical device and global leader in the development of SAM technology, announces the expansion of the nationally recognized continuing medical education program, designed to train, and certify professionals including nurses, athletic trainers, physicians and physical therapists on the use and application of SAM technology. Courses will be led through a SAM Learning Management System virtually by Dr. Rod Walters and Dr. Rajiv Mallipudi, who will...
06Jan
Sustained Acoustic Medicine is an Option for Recovery, Even When Surgery is Not
ZetrOZ Systems, developers of the Sustained Acoustic Medicine (SAM) wearable ultrasound, an FDA-cleared bio regenerative medical device and leader in development of SAM technology announces that SAM is a safe, effective alternative to manage pain and injuries when surgery is not an option. Read more >>
30Dec
ZetrOZ Systems’ Wearable Ultrasound Device, SAM, Receives Expanded FDA Re-Approval, Positioning the Company for Market Growth in 2021
ZetrOZ Systems, developers of the Sustained Acoustic Medicine (SAM) wearable ultrasound, an FDA-cleared bio regenerative medical device, is the global leader in development of SAM technologies. With its reapproval for expanded use in 2020, the use of SAM ultrasound technology in both professional and at-home applications is expected to increase market growth significantly over the next several years. Read more >>
16Dec
New Research Study Shows Efficacy of Sustained Acoustic Medicine as Add-on Therapy in Treating Sport-Related Injuries and Returning Athletes to Play
ZetrOZ Systems, developers of the Sustained Acoustic Medicine (SAM) wearable ultrasound, an FDA-cleared bio regenerative medical device, was recently evaluated in a research study published in the Global Journal of Orthopedics Research, which measured the effectiveness of SAM treatment to reduce pain and improve function in athletes in conjunction with traditional therapies following sports-related musculoskeletal injuries. Read more >>
10Dec
All-Star Athletes Across Sports Are Seeing Injury Recovery Without Surgery or Medication Using SAM 2.0 Wearable Ultrasound
ZetrOZ Systems, developers of the Sustained Acoustic Medicine (SAM) wearable ultrasound, an FDA-cleared bio regenerative medical device supported by the National Institutes of Health, announces that the SAM family of medical ultrasound device has received positive reviews and feedback from professional athletes across a number of different sports and disciplines. The medical device's ability to provide relief from muscle injury and pain showcases SAM's ability to deal with the physical rigors of professional sports and is perfect for home use...
25Nov
ZetrOZ Systems is Selected Among the Most Innovative Healthcare Companies in 2020
ZetrOZ Systems, developers of the SAM family of ultrasound products, FDA-cleared bio regenerative medical devices supported with over 30 clinical efficacy studies, is proud to be recognized as one of the most innovative companies in healthcare, announcing its inclusion into the 2020 Inaugural List of Most Innovative Companies in Healthcare. The 2020 listing of Most Innovative companies in healthcare includes 60 companies from 30 different categories of innovation within the medical industry. Read more >>
18Nov